PAVmed Inc. (PAVM) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

14/25

Growth 4 Margin 1 Expansion 4 Platform 2 Financial 3

latest quarter score

Earnings Reports

14
PAVmed (PAVM) Q2 2026: Strategic Progress Accelerates with Implantable Monitor and EsoGuard Coverage Expansion
August 17, 2026
9
PAVMED (PAVM) Q1 2026: $30M Balance Sheet Reset Unlocks Device Portfolio Relaunch
June 17, 2026
14
PAVM Q4 2025: $100M Asset Base Unlocks Multi-Asset Life Sciences Platform
June 16, 2026
13
Lucid Diagnostics (PAVM) Q2 2025: Revenue Climbs 40% as Medicare Milestone Nears
June 16, 2026
9
PAVM Q3 2025: $900K Quarterly Burn Rate Signals Restructuring Nears Completion
June 16, 2026
11
PAVmed (PAVM) Q1 2025: $40M Proforma Cash Fuels Expansion into Biopharma and Digital Health
May 15, 2025
11
PAVmed (PAVM) Q4 2024: Lucid Test Volume Surges 45% Sequentially, Signaling Growth Trajectory
March 25, 2025

Browse all companies